Cytarabine
NDC 71288-108, Cytarabine, injection, solution, from Meitheal Pharmaceuticals Inc..
- Product NDC
- 71288-108
- Status
- Listed
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206189
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71288-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYTARABINE20 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71288-108-06 | 71288010806 | 5 VIAL, SINGLE-DOSE in 1 CARTON (71288-108-06) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-108-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/446f6765-5375-6368-4755-4944574f5721
Use it
Look up 71288-108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71288-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71288-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.